These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18424866)

  • 21. Cardioembolic stroke: call for a multidisciplinary approach.
    Babarro EG; Rego AR; González-Juanatey JR
    Cerebrovasc Dis; 2009; 27 Suppl 1():82-7. PubMed ID: 19342836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular risk assessment in Australian general practice.
    Gupta R; Stocks NP; Broadbent J
    Aust Fam Physician; 2009 May; 38(5):364-8. PubMed ID: 19458809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardiology 2008].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2008 Jun; 133(25-26):1341-3. PubMed ID: 18553258
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 27. What is the true place of blood pressure in cardiovascular risk management?
    McInnes GT
    J Hypertens; 2007 May; 25(5):925-8. PubMed ID: 17414651
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk associated with interruption of antiplatelet and oral anticoagulation therapy.
    Ferreira JS; Gil VM
    Rev Port Cardiol; 2009; 28(7-8):845-58. PubMed ID: 19894663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.
    Scheltens T; Verschuren WM; Boshuizen HC; Hoes AW; Zuithoff NP; Bots ML; Grobbee DE
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):562-6. PubMed ID: 18756178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive drugs in daily clinical practice: are there differences between genders?
    Barrios V; Escobar C; Echarri R; Jimenez-Nacher JJ
    Eur Heart J; 2009 Mar; 30(5):624. PubMed ID: 19147607
    [No Abstract]   [Full Text] [Related]  

  • 32. Aspirin for all over 50 revisited.
    Elwood P; Morgan G
    Heart; 2008 Nov; 94(11):1364-5. PubMed ID: 18765435
    [No Abstract]   [Full Text] [Related]  

  • 33. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of older hypertensive patients.
    Hedner T; Kjeldsen S; Oparil S; Narkiewics K
    Blood Press; 2008; 17(4):184-5. PubMed ID: 18932064
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnosis and prevention of cardiovascular diseases--Part 2].
    Erbel R
    Herz; 2007 Oct; 32(7):527-8. PubMed ID: 17972025
    [No Abstract]   [Full Text] [Related]  

  • 36. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
    Lubsen J
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
    [No Abstract]   [Full Text] [Related]  

  • 37. [Platelets and heart disease: how much more can basic science influence clinical practice?].
    Flores NA
    Arch Inst Cardiol Mex; 2000; 70(3):213-8. PubMed ID: 10959451
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on the evaluation and management of cardiovascular risk. Introduction.
    Gotto AM
    Am J Cardiol; 2012 Jul; 110(1 Suppl):1A-2A. PubMed ID: 22697389
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiometabolic risk-factor management.
    Ker J
    Cardiovasc J Afr; 2008; 19(4):222-4. PubMed ID: 18776972
    [No Abstract]   [Full Text] [Related]  

  • 40. The metabolic syndrome: definition, diagnosis and management.
    Novo S; Balbarini A; Belch JJ; Bonura F; Clement DL; Diamantopoulos E; Fareed J; Norgren L; Poredos P; Rotzocil K; ; ;
    Int Angiol; 2008 Jun; 27(3):220-31. PubMed ID: 18506125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.